肝脏手术后静脉补铁对贫血、铁代谢及铁调素水平的影响:一项随机对照试验
HepciFer 随机对照试验纳入 50 例肝脏手术患者,术后 4 小时给予羧基麦芽糖铁(15 mg/kg,最大 1 g)或安慰剂。
要点
- 肝脏术后静脉补铁未显著提高术后 7 天血红蛋白水平。
- 静脉补铁可预防功能性缺铁,并克服铁调素介导的铁吸收阻滞。
- 术后补铁应优先选择静脉途径而非口服。
核心结论
- 肝脏术后静脉给予羧基麦芽糖铁未显著增加术后 7 天血红蛋白水平。
- 静脉补铁可预防功能性缺铁,并克服铁调素介导的铁吸收阻滞,应视为术后首选补铁途径。
研究设计与样本
- HepciFer 随机对照试验,纳入 50 例接受肝脏手术的患者。
- 术后 4 小时随机给予羧基麦芽糖铁(15 mg/kg,最大 1 g)或安慰剂。
主要发现
- 静脉补铁组无患者出现功能性缺铁生物学征象。
- 观察期间干预组铁调素水平持续显著高于对照组。
- 炎症标志物、红细胞输血率和住院时间两组相似。
临床怎么用
- 肝脏手术后如需补铁,应优先选择静脉途径以克服铁调素介导的吸收阻滞。
- 静脉补铁可用于预防术后功能性缺铁,但不应预期短期内显著提升血红蛋白。
局限性
- 样本量较小(50 例),可能影响统计效能。
- 仅评估术后 7 天血红蛋白,未报告更长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anemia is a recognized risk factor for perioperative related morbidity and mortality and is frequently reported in liver surgeries with an estimated incidence of 32%. We aim to assess the impact of intravenous iron administration in the immediate postoperative period on anemia and iron status as well as to determine the kinetics of hepcidin after liver surgery. METHODS: The HepciFer trial, a randomized controlled trial, included 50 patients undergoing liver surgery. In accordance with the randomization process, patients received either ferric carboxymaltose (15 mg/kg, maximum 1 g) or placebo 4 hours after surgery. RESULTS: The mean hemoglobin level, 7 days after surgery, did not differ significantly between the intervention and control group (11.1 ± 1.8 g/dL and 10.4 ± 1.6 g/dL, respectively) with a mean difference of +0.7 g/dL ([95% confidence interval, -0.3 to +1.7], P = .173). Within patients receiving intravenous iron supplementation, none presented biological signs of functional iron deficiency. Hepcidin levels remained significantly higher during the observation period in the intervention group. Inflammatory biomarkers, red blood cells transfusion rate and hospital duration of stay were similar between groups. CONCLUSION: Intravenous ferric carboxymaltose administration did not result in a significant increase of hemoglobin levels 7 days after surgery. However, this study suggests that intravenous iron supplementation in the immediate postoperative settings prevents functional iron deficiency. Intravenous iron supplementation overcame the hepcidin-mediated blockade of iron absorption and should be considered as the preferred route of administration in the postoperative period.
引用
- Assouline B, Benoliel A, Zamberg I, et al. Intravenous iron supplementation after liver surgery: Impact on anemia, iron, and hepcidin levels-a randomized controlled trial. Surgery. 2021. PMID: 33888314. doi:10.1016/j.surg.2021.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。